BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.17.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220111T100000
DTEND;TZID=America/Vancouver:20220111T110000
DTSTAMP:20211217T223227Z
CREATED:20211217T223227Z
LAST-MODIFIED:20211217T223227Z
UID:19916-1641895200-1641898800@scienceinvancouver.com
SUMMARY:Gairdner Webinar: Gut Peptides Drive Therapeutic Innovation
DESCRIPTION:Introduction and Q&A Moderator:\n\nDr. Janet Rossant\, President & Scientific Director\, The Gairdner Foundation\n\nSpeaker:\n\nDr. Daniel Drucker\, Professor of Medicine – Department of Medicine\, University of Toronto; Senior Scientist\, Lunenfeld-Tanenbaum Research Institute\, Mt. Sinai Hospital\n\n \nThe Gairdner Foundation is pleased to partner with Life Sciences BC again for a virtual event on January 11 at 10 am PST. The Gairdner Foundation celebrates and recognizes scientific excellence through the Canada Gairdner Awards. Dr. Daniel Drucker received the 2021 Canada Gairdner International Award along with Dr. Jens Holst and Dr. Joel Habener for their research on glucagon-like peptides that has led to major advances in the treatment of Type 2 diabetes\, obesity and intestinal disorders. His lecture is called “Gut peptides drive therapeutic innovation for people with metabolic disorders.” \nPresentation – “Gut peptides drive therapeutic innovation for people with metabolic disorders”.
URL:https://scienceinvancouver.com/event/gairdner-webinar-gut-peptides-drive-therapeutic-innovation/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Gairdner-Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220111T100000
DTEND;TZID=America/Vancouver:20220111T110000
DTSTAMP:20211217T223227Z
CREATED:20211217T223227Z
LAST-MODIFIED:20211217T223227Z
UID:26491-1641895200-1641898800@scienceinvancouver.com
SUMMARY:Gairdner Webinar: Gut Peptides Drive Therapeutic Innovation
DESCRIPTION:Introduction and Q&A Moderator:\n\nDr. Janet Rossant\, President & Scientific Director\, The Gairdner Foundation\n\nSpeaker:\n\nDr. Daniel Drucker\, Professor of Medicine – Department of Medicine\, University of Toronto; Senior Scientist\, Lunenfeld-Tanenbaum Research Institute\, Mt. Sinai Hospital\n\n \nThe Gairdner Foundation is pleased to partner with Life Sciences BC again for a virtual event on January 11 at 10 am PST. The Gairdner Foundation celebrates and recognizes scientific excellence through the Canada Gairdner Awards. Dr. Daniel Drucker received the 2021 Canada Gairdner International Award along with Dr. Jens Holst and Dr. Joel Habener for their research on glucagon-like peptides that has led to major advances in the treatment of Type 2 diabetes\, obesity and intestinal disorders. His lecture is called “Gut peptides drive therapeutic innovation for people with metabolic disorders.” \nPresentation – “Gut peptides drive therapeutic innovation for people with metabolic disorders”.
URL:https://scienceinvancouver.com/event/gairdner-webinar-gut-peptides-drive-therapeutic-innovation-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Gairdner-Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220111T100000
DTEND;TZID=America/Vancouver:20220111T110000
DTSTAMP:20211217T223227Z
CREATED:20211217T223227Z
LAST-MODIFIED:20211217T223227Z
UID:28106-1641895200-1641898800@scienceinvancouver.com
SUMMARY:Gairdner Webinar: Gut Peptides Drive Therapeutic Innovation
DESCRIPTION:Introduction and Q&A Moderator:\n\nDr. Janet Rossant\, President & Scientific Director\, The Gairdner Foundation\n\nSpeaker:\n\nDr. Daniel Drucker\, Professor of Medicine – Department of Medicine\, University of Toronto; Senior Scientist\, Lunenfeld-Tanenbaum Research Institute\, Mt. Sinai Hospital\n\n \nThe Gairdner Foundation is pleased to partner with Life Sciences BC again for a virtual event on January 11 at 10 am PST. The Gairdner Foundation celebrates and recognizes scientific excellence through the Canada Gairdner Awards. Dr. Daniel Drucker received the 2021 Canada Gairdner International Award along with Dr. Jens Holst and Dr. Joel Habener for their research on glucagon-like peptides that has led to major advances in the treatment of Type 2 diabetes\, obesity and intestinal disorders. His lecture is called “Gut peptides drive therapeutic innovation for people with metabolic disorders.” \nPresentation – “Gut peptides drive therapeutic innovation for people with metabolic disorders”.
URL:https://scienceinvancouver.com/event/gairdner-webinar-gut-peptides-drive-therapeutic-innovation-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Gairdner-Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220111T100000
DTEND;TZID=America/Vancouver:20220111T110000
DTSTAMP:20211217T223227Z
CREATED:20211217T223227Z
LAST-MODIFIED:20211217T223227Z
UID:31189-1641895200-1641898800@scienceinvancouver.com
SUMMARY:Gairdner Webinar: Gut Peptides Drive Therapeutic Innovation
DESCRIPTION:Introduction and Q&A Moderator:\n\nDr. Janet Rossant\, President & Scientific Director\, The Gairdner Foundation\n\nSpeaker:\n\nDr. Daniel Drucker\, Professor of Medicine – Department of Medicine\, University of Toronto; Senior Scientist\, Lunenfeld-Tanenbaum Research Institute\, Mt. Sinai Hospital\n\n \nThe Gairdner Foundation is pleased to partner with Life Sciences BC again for a virtual event on January 11 at 10 am PST. The Gairdner Foundation celebrates and recognizes scientific excellence through the Canada Gairdner Awards. Dr. Daniel Drucker received the 2021 Canada Gairdner International Award along with Dr. Jens Holst and Dr. Joel Habener for their research on glucagon-like peptides that has led to major advances in the treatment of Type 2 diabetes\, obesity and intestinal disorders. His lecture is called “Gut peptides drive therapeutic innovation for people with metabolic disorders.” \nPresentation – “Gut peptides drive therapeutic innovation for people with metabolic disorders”.
URL:https://scienceinvancouver.com/event/gairdner-webinar-gut-peptides-drive-therapeutic-innovation-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Gairdner-Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220111T100000
DTEND;TZID=America/Vancouver:20220111T110000
DTSTAMP:20211217T223227Z
CREATED:20211217T223227Z
LAST-MODIFIED:20211217T223227Z
UID:32649-1641895200-1641898800@scienceinvancouver.com
SUMMARY:Gairdner Webinar: Gut Peptides Drive Therapeutic Innovation
DESCRIPTION:Introduction and Q&A Moderator:\n\nDr. Janet Rossant\, President & Scientific Director\, The Gairdner Foundation\n\nSpeaker:\n\nDr. Daniel Drucker\, Professor of Medicine – Department of Medicine\, University of Toronto; Senior Scientist\, Lunenfeld-Tanenbaum Research Institute\, Mt. Sinai Hospital\n\n \nThe Gairdner Foundation is pleased to partner with Life Sciences BC again for a virtual event on January 11 at 10 am PST. The Gairdner Foundation celebrates and recognizes scientific excellence through the Canada Gairdner Awards. Dr. Daniel Drucker received the 2021 Canada Gairdner International Award along with Dr. Jens Holst and Dr. Joel Habener for their research on glucagon-like peptides that has led to major advances in the treatment of Type 2 diabetes\, obesity and intestinal disorders. His lecture is called “Gut peptides drive therapeutic innovation for people with metabolic disorders.” \nPresentation – “Gut peptides drive therapeutic innovation for people with metabolic disorders”.
URL:https://scienceinvancouver.com/event/gairdner-webinar-gut-peptides-drive-therapeutic-innovation-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/Gairdner-Webinar.png
END:VEVENT
END:VCALENDAR